Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Zymeworks Inc. (ZYME) Balance Sheet

As of 2026-06-30 (10-Q), Zymeworks Inc. (ZYME) reported total assets of $397.0M, total liabilities of $316.6M and shareholders' equity of $80.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $179.4M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ZYMEZymeworks Inc.Follow ZYME — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.0B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
9 Nov, in 16 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents400.9157.666.141.2179.4
Short-term investments91.3216.8———
Receivables33.419.555.84.65.9
Current assets544.7412.9300.5248.8298.4
Total assets648.7580.9463.1346.5397.0
Current liabilities95.655.888.342.347.2
Total liabilities155.8116.1124.378.0316.6
Shareholders' equity493.0464.8338.8268.580.4

USD millions · SEC XBRL

Zymeworks Inc. — questions

How much cash does Zymeworks Inc. have?
$179.4M in cash and cash equivalents as of 2026-06-30.
What are Zymeworks Inc.'s total assets?
$397.0M as of 2026-06-30.
What is Zymeworks Inc.'s shareholders' equity?
$80.4M as of 2026-06-30.

Every figure on this page comes from Zymeworks Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.